Central Hospital Affiliated to Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250013, China.
School of Clinical Medicine, Weifang Medical University, Weifang, China.
Biomed Pharmacother. 2022 Sep;153:113500. doi: 10.1016/j.biopha.2022.113500. Epub 2022 Aug 4.
Spinal cord injury (SCI) triggers complex inflammatory and pathological processes that ultimately lead to scar formation, thus resulting in the severe and irreversible loss of function. The composition of spinal cord scars in SCI can be divided into cellular components and non-cellular components such as the extracellular matrix (ECM). Studies targeting the ECM, such as chondroitin sulfate proteoglycans (CSPGs), have achieved promising therapeutic results. On the other hand, with the application of new techniques in the field of SCI, an increasing body of research has been targeted to the complex mechanisms that occur in the cellular components during scar formation. Here, we meticulously describe the spatial distribution and dynamic changes of the cellular components involved in the formation of scars following SCI, including microglia, astrocytes, fibroblasts, and macrophages, paying particular attention to the recent application of new technologies. In addition, we outline the therapeutic approaches that target the cellular components of scar formation and explore potential therapeutic measures to improve functional recovery after SCI.
脊髓损伤 (SCI) 会引发复杂的炎症和病理过程,最终导致疤痕形成,从而导致严重且不可逆转的功能丧失。SCI 中脊髓疤痕的组成可以分为细胞成分和细胞外基质 (ECM) 等非细胞成分。针对 ECM 的研究,例如硫酸软骨素蛋白聚糖 (CSPGs),已经取得了有前景的治疗效果。另一方面,随着 SCI 领域新技术的应用,越来越多的研究针对疤痕形成过程中细胞成分中发生的复杂机制。在这里,我们详细描述了 SCI 后疤痕形成过程中涉及的细胞成分的空间分布和动态变化,包括小胶质细胞、星形胶质细胞、成纤维细胞和巨噬细胞,并特别关注新技术的最近应用。此外,我们概述了针对疤痕形成的细胞成分的治疗方法,并探讨了改善 SCI 后功能恢复的潜在治疗措施。